(NASDAQ: PEPG) Pepgen's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Pepgen's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast PEPG's revenue for 2027 to be $402,467,599, with the lowest PEPG revenue forecast at $402,467,599, and the highest PEPG revenue forecast at $402,467,599. On average, 2 Wall Street analysts forecast PEPG's revenue for 2028 to be $1,149,159,518, with the lowest PEPG revenue forecast at $779,412,862, and the highest PEPG revenue forecast at $1,518,906,174.
In 2029, PEPG is forecast to generate $4,067,867,634 in revenue, with the lowest revenue forecast at $3,998,172,025 and the highest revenue forecast at $4,137,563,242.